Hinge Health bags $600M investment from Coatue, Tiger Global, boosting valuation to $6.2B
Fierce Healthcare
OCTOBER 28, 2021
Hinge Health bags $600M investment from Coatue, Tiger Global, boosting valuation to $6.2B. hlandi. Thu, 10/28/2021 - 11:00.
Sat.Oct 23, 2021 - Fri.Oct 29, 2021
144 
Strike two for Novartis’ lung cancer antibody canakinumab
pharmaphorum
OCTOBER 25, 2021
Expectations for Novartis’ canakinumab as a therapy for cancer have taken another dive, after a second phase 3 trial in non-small cell lung cancer (NSCLC) failed to meet its primary objectives. Novartis isn’t giving up on the programme yet, as it still has other trials of canakinumab in play, but the latest failure makes prospects for the antibody in oncology look increasingly remote.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Potential COVID-19 treatment to wrap up Phase III trial
Outsourcing Pharma
OCTOBER 26, 2021
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.
10 Tips On How To Get Started With Agile Marketing
Pharma Marketing Network
OCTOBER 27, 2021
What is Agile Marketing Exactly? Agile marketing is the application of agile values and principles to manage the way a marketing team gets work done. At its core, an agile approach values flexibility, iteration, and speed. It enables you to quickly learn what does and does not work, so you can incrementally improve the results of your marketing efforts.*. * Source: AHA!
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Google taps Headspace executive to lead tech-driven mental health efforts
Fierce Healthcare
OCTOBER 26, 2021
Google taps Headspace executive to lead tech-driven mental health efforts. hlandi. Tue, 10/26/2021 - 11:58.
Bayer, One Drop launch AI tool for heart disease prevention
pharmaphorum
OCTOBER 27, 2021
Bayer’s two-year-old digital health collaboration with One Drop has borne its first fruit, an artificial intelligence-powered software module for preventing cardiovascular disease (CVD). The German pharmaceutical company has been working with New York-based One Drop on digital health products that span multiple therapeutic areas, including oncology and women’s health as well as CVD in the alliance , which was expanded last year in a $98 million deal.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
UK COVID-19 patients able to take GP prescribed medicine at home
Pharma Times
OCTOBER 26, 2021
The drug acts by inhibiting SARS-CoV-2 from replicating in the human system
Healthcare is in an era of 'hyper-innovation' as executives look to ramp up digital tech: survey
Fierce Healthcare
OCTOBER 28, 2021
Healthcare is in an era of 'hyper-innovation' as executives look to ramp up digital tech: survey. rtorrence. Thu, 10/28/2021 - 16:57.
Sustained healthcare systems need sustainable pharma business models
pharmaphorum
OCTOBER 26, 2021
COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing. But can the Pharmaceutical Strategy for Europe help to redress the balance? Only sustainable, robust supply chains and business models will allow innovation to flourish, secure access to medicines, and minimise the industry’s impact on the environment.
Potential COVID-19 treatment to kick off Phase III trial
Outsourcing Pharma
OCTOBER 26, 2021
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Priority review for Novartis CAR-T cell therapy Kymriah
Pharma Times
OCTOBER 27, 2021
Novartis is eyeing approval for Kymriah to treat adult patients with relapsed or refractory follicular lymphoma
Clover Health: Open networks encourage patient choice, promote health equity
Fierce Healthcare
OCTOBER 27, 2021
Clover Health: Open networks encourage patient choice, promote health equity. rtorrence. Wed, 10/27/2021 - 14:48.
Luminopia scores FDA approval for TV-based amblyopia therapy
pharmaphorum
OCTOBER 25, 2021
Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital therapeutic (DTx) for amblyopia or lazy eye in children that is based on watching TV shows. The DTx is TV watching with a difference, of course – namely specially modified TV shows and movies that are viewed using a virtual reality headset designed to promote use of the weaker eye in amblyopia, which is a leading cause of vision loss in children.
Speaking the language of diverse patient populations is vital: TransPerfect
Outsourcing Pharma
OCTOBER 25, 2021
A leader from the language and tech solutions firm explains how multilingual support can improve patient recruitment and other aspects of clinical trials.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The New Killer App? Platforms in Healthcare
Pharma Marketing Network
OCTOBER 27, 2021
The healthcare burden continues to increase and the complexity continues to grow. There is a high volume of inefficiencies in the market, which is becoming increasingly fragmented due to the infusion of venture capital dollars over the last five-plus years and the thousands of start-up companies focused on addressing some aspect of healthcare. A digital platform typically refers to a digital service or digital product with an integrated business model and operational model.
Alexa is finding a voice in healthcare. Cedars-Sinai, Boston Children's sign on for new Amazon smart hospital service
Fierce Healthcare
OCTOBER 24, 2021
Alexa is finding a voice in healthcare. Cedars-Sinai, Boston Children's sign on for new Amazon smart hospital service. hlandi. Sun, 10/24/2021 - 21:46.
Speak like a leader: 15 secrets to engage any audience
pharmaphorum
OCTOBER 28, 2021
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post on delivering a seemingly effortless talk also incorporates select insights from Executive Speaking Success’ John Bates. Public speaking is the original human communication method.
Survey: pandemic viewed as catalyst for positive change in trials
Outsourcing Pharma
OCTOBER 26, 2021
According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Double vaccinated can still spread COVID-19 at home, says UK study
Pharma Times
OCTOBER 29, 2021
Experts say that it is vital to ensure that every member who is eligible for a vaccine has received one
Aetna exec: Retail-based programs connect Medicare members to health resources they trust
Fierce Healthcare
OCTOBER 27, 2021
Aetna exec: Retail-based programs connect Medicare members to health resources they trust. dmuoio. Wed, 10/27/2021 - 16:11.
Takeda buys GammaDelta to boost cancer cell therapy credentials
pharmaphorum
OCTOBER 28, 2021
Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in ‘off-the-shelf’ cell therapies for solid tumours and blood cancers. The two companies have been working together since 2017, with Takeda pledging $100 million to help GammaDelta advance its cell therapy platform as part of a “build-to-buy” arrangement.
Global Genes partners to elevate equity for rare disease patients
Outsourcing Pharma
OCTOBER 25, 2021
The radvocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.
Rishi Sunak promises £6 billion package for health service
Pharma Times
OCTOBER 25, 2021
Package was announced during a speech at the annual Conservative Party Conference in Manchester, UK
Most healthcare executives don't trust their organization's data, survey finds
Fierce Healthcare
OCTOBER 26, 2021
Most healthcare executives don't trust their organization's data, survey finds. agliadkovskaya. Tue, 10/26/2021 - 19:46.
Cerner Enviza aims to accelerate therapies and improve patient outcomes
pharmaphorum
OCTOBER 28, 2021
Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered. Kansas City, Mo. — Oct. 26, 2021 — Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, Cerner Enviza SM , that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights.
How can clinical research be truly patient centric?
Outsourcing Pharma
OCTOBER 28, 2021
During OSPâs November 17 online event, a group of experts will offer insights, advice, and examples of solutions that put patients at the center of studies.
NICE does not recommend tucatinib for advanced breast cancer
Pharma Times
OCTOBER 26, 2021
Tucatinib, a tyrosine kinase inhibitor, works by blocking a specific area of the HER2 gene in cancer cells
A look at Anthem, Kroger's new co-branded Medicare Advantage plans
Fierce Healthcare
OCTOBER 26, 2021
A look at Anthem, Kroger's new co-branded Medicare Advantage plans. pminemyer. Tue, 10/26/2021 - 15:06.
Patient engagement strategies: the pharmaphorum podcast
pharmaphorum
OCTOBER 29, 2021
This episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinician, consultant and patient advocate. Here he takes a helicopter view of patient engagement in a discussion with MSD’s European lead for patient innovation Paul Robinson, that’s moderated by pharmaphorum’s former web editor Catherine Longworth.
Increased representation benefits cancer clinical trials: Science 37
Outsourcing Pharma
OCTOBER 28, 2021
An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.
EC approves Keytruda regimen for triple-negative breast cancer
Pharma Times
OCTOBER 25, 2021
Approval covers patients with locally recurrent or metastatic TNBC
CHS earnings, revenue hold steady in Q3 despite 'largest number of COVID-19 cases to date'
Fierce Healthcare
OCTOBER 27, 2021
CHS earnings, revenue hold steady in Q3 despite 'largest number of COVID-19 cases to date'. dmuoio. Wed, 10/27/2021 - 17:14.
FDA clears Roche’s Susvimo implant for eye disease wet AMD
pharmaphorum
OCTOBER 24, 2021
Roche’s Genentech unit has won FDA approval for Susvimo, an implant for eyesight-robbing disease wet age-related macular degeneration (AMD) that gives patients an alternative to regular injections into the eye. Susvimo has the same active ingredient as Roche’s big-selling therapy Lucentis (ranibizumab), a VEGF inhibitor administered once a month that has been approved by the FDA since 2006 for wet AMD.
Let's personalize your content